fanta.bio Sample: CNhs10874
- Species
- human
- CRE Type
- ELA
- Cluster
- 0
- Cell Type Class
- Cardiovascular
17376 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1262 / 14814 (8.5%) | 344 / 148140 (0.2%) | −324.0 | −324.0 | 36.69 |
| HIF1A SRX11007095 | HK-2 Kidney | 2495 / 14814 (16.8%) | 748 / 148140 (0.5%) | −324.0 | −324.0 | 33.36 |
| TP53 SRX19538274 | U2OS Bone | 473 / 14814 (3.2%) | 148 / 148140 (0.1%) | −324.0 | −324.0 | 31.96 |
| TP53 SRX19538268 | U2OS Bone | 468 / 14814 (3.2%) | 150 / 148140 (0.1%) | −324.0 | −324.0 | 31.20 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1847 / 14814 (12.5%) | 616 / 148140 (0.4%) | −324.0 | −324.0 | 29.98 |
| TP53 SRX19538276 | U2OS Bone | 463 / 14814 (3.1%) | 158 / 148140 (0.1%) | −324.0 | −324.0 | 29.30 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1805 / 14814 (12.2%) | 660 / 148140 (0.4%) | −324.0 | −324.0 | 27.35 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2545 / 14814 (17.2%) | 983 / 148140 (0.7%) | −324.0 | −324.0 | 25.89 |
| TP53 SRX19538279 | Osteoblasts Bone | 581 / 14814 (3.9%) | 225 / 148140 (0.2%) | −324.0 | −324.0 | 25.82 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2448 / 14814 (16.5%) | 976 / 148140 (0.7%) | −324.0 | −324.0 | 25.08 |
| HIF1A SRX20663235 | HK-2 Kidney | 538 / 14814 (3.6%) | 241 / 148140 (0.2%) | −324.0 | −324.0 | 22.32 |
| SCML2 SRX644728 | 293 Kidney | 1464 / 14814 (9.9%) | 659 / 148140 (0.4%) | −324.0 | −324.0 | 22.22 |
| FOXP1 SRX736067 | LNCAP Prostate | 1834 / 14814 (12.4%) | 1036 / 148140 (0.7%) | −324.0 | −324.0 | 17.70 |
| MYH11 SRX265221 | ME-1 Blood | 878 / 14814 (5.9%) | 541 / 148140 (0.4%) | −324.0 | −324.0 | 16.23 |
| BRD4 SRX9419935 | BT-474 Breast | 3630 / 14814 (24.5%) | 2441 / 148140 (1.6%) | −324.0 | −324.0 | 14.87 |
| MED1 SRX9419944 | BT-474 Breast | 3521 / 14814 (23.8%) | 2403 / 148140 (1.6%) | −324.0 | −324.0 | 14.65 |
| MED1 SRX9419945 | BT-474 Breast | 3580 / 14814 (24.2%) | 2445 / 148140 (1.7%) | −324.0 | −324.0 | 14.64 |
| BRD4 SRX9419937 | BT-474 Breast | 3595 / 14814 (24.3%) | 2467 / 148140 (1.7%) | −324.0 | −324.0 | 14.57 |
| MED1 SRX9419946 | BT-474 Breast | 3656 / 14814 (24.7%) | 2576 / 148140 (1.7%) | −324.0 | −324.0 | 14.19 |
| BRD4 SRX9419936 | BT-474 Breast | 3655 / 14814 (24.7%) | 2582 / 148140 (1.7%) | −324.0 | −324.0 | 14.16 |
| BRD4 SRX9419938 | BT-474 Breast | 3620 / 14814 (24.4%) | 2571 / 148140 (1.7%) | −324.0 | −324.0 | 14.08 |
| MED1 SRX9419947 | BT-474 Breast | 3538 / 14814 (23.9%) | 2547 / 148140 (1.7%) | −324.0 | −324.0 | 13.89 |
| EZH2 SRX2146136 | LNCAP Prostate | 7750 / 14814 (52.3%) | 7083 / 148140 (4.8%) | −324.0 | −324.0 | 10.94 |
| BRD4 SRX736201 | 90-8TL Neural | 6073 / 14814 (41.0%) | 5812 / 148140 (3.9%) | −324.0 | −324.0 | 10.45 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 759 / 14814 (5.1%) | 814 / 148140 (0.5%) | −324.0 | −324.0 | 9.32 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1785 / 14814 (12.0%) | 2378 / 148140 (1.6%) | −324.0 | −324.0 | 7.51 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1499 / 14814 (10.1%) | 3269 / 148140 (2.2%) | −324.0 | −324.0 | 4.59 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1663 / 14814 (11.2%) | 4463 / 148140 (3.0%) | −324.0 | −324.0 | 3.73 |
| AGO2 SRX4708039 | Hep G2 Liver | 1950 / 14814 (13.2%) | 6652 / 148140 (4.5%) | −324.0 | −324.0 | 2.93 |
| TP53 SRX19538280 | Osteoblasts Bone | 449 / 14814 (3.0%) | 174 / 148140 (0.1%) | −318.5 | −315.4 | 25.80 |
| TP53 SRX19538267 | U2OS Bone | 422 / 14814 (2.8%) | 132 / 148140 (0.1%) | −316.5 | −313.4 | 31.97 |
| TP53 SRX19538273 | U2OS Bone | 417 / 14814 (2.8%) | 134 / 148140 (0.1%) | −310.6 | −307.6 | 31.12 |
| TP53 SRX19538281 | Osteoblasts Bone | 483 / 14814 (3.3%) | 257 / 148140 (0.2%) | −310.4 | −307.4 | 18.79 |
| TP53 SRX19538275 | U2OS Bone | 420 / 14814 (2.8%) | 149 / 148140 (0.1%) | −305.1 | −302.1 | 28.19 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 684 / 14814 (4.6%) | 844 / 148140 (0.6%) | −297.4 | −294.5 | 8.10 |
| PBX4 SRX2731658 | PC-3 Prostate | 833 / 14814 (5.6%) | 23388 / 148140 (15.8%) | −296.7 | −293.7 | 0.36 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 433 / 14814 (2.9%) | 189 / 148140 (0.1%) | −296.6 | −293.7 | 22.91 |
| RUNX1 SRX2513054 | 293 Kidney | 3219 / 14814 (21.7%) | 15764 / 148140 (10.6%) | −295.8 | −292.8 | 2.04 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 683 / 14814 (4.6%) | 885 / 148140 (0.6%) | −288.0 | −285.1 | 7.72 |
| 5-mC SRX882970 | LNCAP Prostate | 2857 / 14814 (19.3%) | 13363 / 148140 (9.0%) | −286.3 | −283.4 | 2.14 |
| IRF3 SRX11453858 | Hep G2 Liver | 338 / 14814 (2.3%) | 57 / 148140 (0.0%) | −286.3 | −283.4 | 59.30 |
| TP53 SRX19538269 | U2OS Bone | 498 / 14814 (3.4%) | 364 / 148140 (0.2%) | −283.1 | −280.2 | 13.68 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2116 / 14814 (14.3%) | 8611 / 148140 (5.8%) | −271.4 | −268.5 | 2.46 |
| 5-mC SRX882968 | LNCAP Prostate | 2790 / 14814 (18.8%) | 13223 / 148140 (8.9%) | −270.7 | −267.8 | 2.11 |
| TP53 SRX19538270 | U2OS Bone | 474 / 14814 (3.2%) | 361 / 148140 (0.2%) | −264.6 | −261.8 | 13.13 |
| Epitope tags SRX10549776 | K-562 Blood | 1421 / 14814 (9.6%) | 4636 / 148140 (3.1%) | −253.3 | −250.5 | 3.07 |
| FOXA1 SRX4815198 | MCF-7 Breast | 800 / 14814 (5.4%) | 21366 / 148140 (14.4%) | −250.6 | −247.7 | 0.37 |
| BRD1 SRX286203 | RKO Digestive tract | 1236 / 14814 (8.3%) | 3675 / 148140 (2.5%) | −248.3 | −245.4 | 3.36 |
| BRD4 SRX736204 | 90-8TL Neural | 1001 / 14814 (6.8%) | 2480 / 148140 (1.7%) | −247.6 | −244.8 | 4.04 |
| KAT7 SRX101303 | RKO Digestive tract | 1391 / 14814 (9.4%) | 4553 / 148140 (3.1%) | −246.6 | −243.7 | 3.06 |
| TP53 SRX19538282 | Osteoblasts Bone | 409 / 14814 (2.8%) | 262 / 148140 (0.2%) | −245.3 | −242.5 | 15.61 |
| FOXA1 SRX4815197 | MCF-7 Breast | 571 / 14814 (3.9%) | 17496 / 148140 (11.8%) | −239.8 | −237.0 | 0.33 |
| 5-mC SRX882965 | LNCAP Prostate | 2284 / 14814 (15.4%) | 10350 / 148140 (7.0%) | −238.8 | −236.0 | 2.21 |
| TP53 SRX19538271 | U2OS Bone | 660 / 14814 (4.5%) | 1072 / 148140 (0.7%) | −237.6 | −234.8 | 6.16 |
| IRF3 SRX11453861 | Hep G2 Liver | 287 / 14814 (1.9%) | 58 / 148140 (0.0%) | −235.7 | −232.9 | 49.48 |
| CIC SRX13262055 | Astrocytes Neural | 2887 / 14814 (19.5%) | 14822 / 148140 (10.0%) | −232.2 | −229.5 | 1.95 |
| FOXA1 SRX176862 | MCF-7 Breast | 279 / 14814 (1.9%) | 12283 / 148140 (8.3%) | −231.8 | −229.0 | 0.23 |
| FOS SRX150477 | MCF 10A Breast | 584 / 14814 (3.9%) | 17379 / 148140 (11.7%) | −230.0 | −227.2 | 0.34 |
| FOXA1 SRX176863 | MCF-7 Breast | 253 / 14814 (1.7%) | 11712 / 148140 (7.9%) | −228.9 | −226.2 | 0.22 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 536 / 14814 (3.6%) | 16469 / 148140 (11.1%) | −225.3 | −222.5 | 0.33 |
| FOS SRX150478 | MCF 10A Breast | 622 / 14814 (4.2%) | 17787 / 148140 (12.0%) | −224.3 | −221.6 | 0.35 |
| KAT6A SRX20971022 | Fibroblasts Others | 274 / 14814 (1.8%) | 60 / 148140 (0.0%) | −221.7 | −219.0 | 45.67 |
| AGO2 SRX6783958 | Hep G2 Liver | 1223 / 14814 (8.3%) | 3930 / 148140 (2.7%) | −221.3 | −218.6 | 3.11 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1364 / 14814 (9.2%) | 4781 / 148140 (3.2%) | −218.2 | −215.5 | 2.85 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 504 / 14814 (3.4%) | 626 / 148140 (0.4%) | −217.7 | −215.0 | 8.05 |
| BRPF3 SRX796084 | RKO Digestive tract | 1485 / 14814 (10.0%) | 5528 / 148140 (3.7%) | −216.7 | −214.0 | 2.69 |
| BRPF3 SRX796085 | RKO Digestive tract | 1088 / 14814 (7.3%) | 3255 / 148140 (2.2%) | −215.8 | −213.1 | 3.34 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1704 / 14814 (11.5%) | 6930 / 148140 (4.7%) | −215.2 | −212.5 | 2.46 |
| AGO2 SRX6783957 | Hep G2 Liver | 1220 / 14814 (8.2%) | 4030 / 148140 (2.7%) | −212.2 | −209.6 | 3.03 |
| ESR1 SRX20282961 | MCF-7 Breast | 301 / 14814 (2.0%) | 11974 / 148140 (8.1%) | −207.8 | −205.1 | 0.25 |
| FOXA1 SRX1161177 | MCF-7 Breast | 228 / 14814 (1.5%) | 10627 / 148140 (7.2%) | −207.7 | −205.1 | 0.21 |
| TRP47 SRX4548329 | THP-1 Blood | 2469 / 14814 (16.7%) | 12353 / 148140 (8.3%) | −207.6 | −204.9 | 2.00 |
| FOXA1 SRX3931044 | MCF-7 Breast | 556 / 14814 (3.8%) | 16177 / 148140 (10.9%) | −206.9 | −204.3 | 0.34 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 820 / 14814 (5.5%) | 1991 / 148140 (1.3%) | −206.3 | −203.7 | 4.12 |
| BRPF3 SRX796086 | RKO Digestive tract | 1407 / 14814 (9.5%) | 5217 / 148140 (3.5%) | −206.3 | −203.6 | 2.70 |
| ESR1 SRX7624157 | MCF-7 Breast | 689 / 14814 (4.7%) | 18180 / 148140 (12.3%) | −206.0 | −203.4 | 0.38 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 283 / 14814 (1.9%) | 102 / 148140 (0.1%) | −204.6 | −201.9 | 27.75 |
| AR SRX10820653 | LNCAP Prostate | 326 / 14814 (2.2%) | 185 / 148140 (0.1%) | −204.6 | −201.9 | 17.62 |
| ESR1 SRX371469 | MCF-7 Breast | 241 / 14814 (1.6%) | 10772 / 148140 (7.3%) | −204.4 | −201.8 | 0.22 |
| FOXA1 SRX371482 | MCF-7 Breast | 361 / 14814 (2.4%) | 12884 / 148140 (8.7%) | −203.3 | −200.7 | 0.28 |
| SREBF2 SRX5359048 | HCC70 Breast | 1641 / 14814 (11.1%) | 6733 / 148140 (4.5%) | −203.2 | −200.6 | 2.44 |
| GATA3 SRX190239 | MCF-7 Breast | 370 / 14814 (2.5%) | 13012 / 148140 (8.8%) | −202.4 | −199.8 | 0.28 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1139 / 14814 (7.7%) | 3706 / 148140 (2.5%) | −202.0 | −199.4 | 3.07 |
| ESR1 SRX371478 | MCF-7 Breast | 318 / 14814 (2.1%) | 12088 / 148140 (8.2%) | −201.8 | −199.2 | 0.26 |
| ESR1 SRX4367193 | MCF-7 Breast | 893 / 14814 (6.0%) | 20947 / 148140 (14.1%) | −200.5 | −197.9 | 0.43 |
| ESR1 SRX7624156 | MCF-7 Breast | 409 / 14814 (2.8%) | 13576 / 148140 (9.2%) | −199.7 | −197.1 | 0.30 |
| TLE3 SRX4815191 | MCF-7 Breast | 229 / 14814 (1.5%) | 10370 / 148140 (7.0%) | −198.3 | −195.8 | 0.22 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 630 / 14814 (4.3%) | 1207 / 148140 (0.8%) | −198.2 | −195.6 | 5.22 |
| FOXA1 SRX371481 | MCF-7 Breast | 259 / 14814 (1.7%) | 10909 / 148140 (7.4%) | −197.6 | −195.0 | 0.24 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 282 / 14814 (1.9%) | 11310 / 148140 (7.6%) | −197.1 | −194.5 | 0.25 |
| YAP1 SRX757325 | H2052 Lung | 709 / 14814 (4.8%) | 18094 / 148140 (12.2%) | −195.1 | −192.5 | 0.39 |
| FOXA1 SRX371483 | MCF-7 Breast | 283 / 14814 (1.9%) | 11229 / 148140 (7.6%) | −193.8 | −191.2 | 0.25 |
| FOXA1 SRX1161173 | MCF-7 Breast | 184 / 14814 (1.2%) | 9322 / 148140 (6.3%) | −192.1 | −189.5 | 0.20 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 291 / 14814 (2.0%) | 11299 / 148140 (7.6%) | −191.5 | −189.0 | 0.26 |
| TP53 SRX396254 | Fibroblasts Others | 876 / 14814 (5.9%) | 2419 / 148140 (1.6%) | −190.9 | −188.4 | 3.62 |
| ING5 SRX286202 | RKO Digestive tract | 1270 / 14814 (8.6%) | 4631 / 148140 (3.1%) | −190.4 | −187.9 | 2.74 |
| MEAF6 DRX234811 | 293 Kidney | 1602 / 14814 (10.8%) | 6728 / 148140 (4.5%) | −189.7 | −187.1 | 2.38 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 599 / 14814 (4.0%) | 16221 / 148140 (10.9%) | −188.7 | −186.2 | 0.37 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 477 / 14814 (3.2%) | 680 / 148140 (0.5%) | −188.2 | −185.7 | 7.01 |
| ESR1 SRX176860 | MCF-7 Breast | 446 / 14814 (3.0%) | 13787 / 148140 (9.3%) | −187.5 | −185.0 | 0.32 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1561 / 14814 (10.5%) | 6512 / 148140 (4.4%) | −186.9 | −184.4 | 2.40 |
| TP53 SRX19538272 | U2OS Bone | 554 / 14814 (3.7%) | 976 / 148140 (0.7%) | −186.8 | −184.3 | 5.68 |
| ESR1 SRX20282960 | MCF-7 Breast | 299 / 14814 (2.0%) | 11289 / 148140 (7.6%) | −186.6 | −184.1 | 0.26 |
| AR SRX10820651 | LNCAP Prostate | 337 / 14814 (2.3%) | 266 / 148140 (0.2%) | −185.0 | −182.5 | 12.67 |
| ESR1 SRX371479 | MCF-7 Breast | 237 / 14814 (1.6%) | 10121 / 148140 (6.8%) | −184.8 | −182.3 | 0.23 |
| MEAF6 DRX300417 | 293 Kidney | 1467 / 14814 (9.9%) | 5957 / 148140 (4.0%) | −184.1 | −181.6 | 2.46 |
| FOS SRX4192880 | MCF 10A Breast | 472 / 14814 (3.2%) | 14085 / 148140 (9.5%) | −184.0 | −181.5 | 0.34 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1710 / 14814 (11.5%) | 7557 / 148140 (5.1%) | −183.8 | −181.4 | 2.26 |
| ESR1 SRX176861 | MCF-7 Breast | 458 / 14814 (3.1%) | 13850 / 148140 (9.3%) | −183.6 | −181.1 | 0.33 |
| ESR1 SRX371470 | ZR-75-1 Breast | 221 / 14814 (1.5%) | 9785 / 148140 (6.6%) | −183.5 | −181.1 | 0.23 |
| YAP1 SRX757326 | H2052 Lung | 609 / 14814 (4.1%) | 16171 / 148140 (10.9%) | −183.0 | −180.5 | 0.38 |
| ESR1 SRX371471 | ZR-75-1 Breast | 279 / 14814 (1.9%) | 10810 / 148140 (7.3%) | −182.5 | −180.0 | 0.26 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 619 / 14814 (4.2%) | 1276 / 148140 (0.9%) | −182.4 | −179.9 | 4.85 |
| ESR1 SRX20282939 | MCF-7 Breast | 306 / 14814 (2.1%) | 11252 / 148140 (7.6%) | −181.3 | −178.9 | 0.27 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 243 / 14814 (1.6%) | 10084 / 148140 (6.8%) | −179.9 | −177.5 | 0.24 |
| FOXA1 SRX1161175 | MCF-7 Breast | 184 / 14814 (1.2%) | 8972 / 148140 (6.1%) | −179.9 | −177.4 | 0.21 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 474 / 14814 (3.2%) | 13980 / 148140 (9.4%) | −179.9 | −177.4 | 0.34 |
| ESR1 SRX371467 | MCF-7 Breast | 276 / 14814 (1.9%) | 10676 / 148140 (7.2%) | −179.7 | −177.3 | 0.26 |
| Epitope tags DRX443510 | 293 Kidney | 1381 / 14814 (9.3%) | 5489 / 148140 (3.7%) | −179.6 | −177.1 | 2.52 |
| ESR1 SRX194569 | MCF-7 Breast | 274 / 14814 (1.8%) | 10631 / 148140 (7.2%) | −179.6 | −177.1 | 0.26 |
| ESR1 SRX1531791 | MCF-7 Breast | 252 / 14814 (1.7%) | 10229 / 148140 (6.9%) | −179.3 | −176.9 | 0.25 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1770 / 14814 (11.9%) | 8064 / 148140 (5.4%) | −178.8 | −176.4 | 2.19 |
| FOXA1 SRX1161176 | MCF-7 Breast | 256 / 14814 (1.7%) | 10280 / 148140 (6.9%) | −178.6 | −176.2 | 0.25 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1795 / 14814 (12.1%) | 8244 / 148140 (5.6%) | −178.5 | −176.0 | 2.18 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 394 / 14814 (2.7%) | 12634 / 148140 (8.5%) | −178.1 | −175.7 | 0.31 |
| ESR1 SRX371468 | MCF-7 Breast | 154 / 14814 (1.0%) | 8320 / 148140 (5.6%) | −177.9 | −175.5 | 0.19 |
| STAT5B SRX831881 | CD8+ T cells Blood | 265 / 14814 (1.8%) | 125 / 148140 (0.1%) | −177.1 | −174.7 | 21.20 |
| ESR1 SRX194572 | MCF-7 Breast | 153 / 14814 (1.0%) | 8270 / 148140 (5.6%) | −176.9 | −174.5 | 0.19 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 193 / 14814 (1.3%) | 9046 / 148140 (6.1%) | −176.5 | −174.1 | 0.21 |
| ESR1 SRX371476 | MCF-7 Breast | 188 / 14814 (1.3%) | 8923 / 148140 (6.0%) | −175.6 | −173.2 | 0.21 |
| MITF SRX1555436 | 501A Epidermis | 1801 / 14814 (12.2%) | 8369 / 148140 (5.6%) | −174.5 | −172.1 | 2.15 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1612 / 14814 (10.9%) | 7087 / 148140 (4.8%) | −174.4 | −172.0 | 2.27 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 230 / 14814 (1.6%) | 9680 / 148140 (6.5%) | −174.4 | −172.0 | 0.24 |
| ARID1A SRX5089376 | MCF-7 Breast | 224 / 14814 (1.5%) | 9525 / 148140 (6.4%) | −173.0 | −170.6 | 0.24 |
| LEO1 SRX1873456 | SEM Blood | 1362 / 14814 (9.2%) | 5488 / 148140 (3.7%) | −172.6 | −170.2 | 2.48 |
| MECOM SRX23677885 | HNT-34 Blood | 1630 / 14814 (11.0%) | 7245 / 148140 (4.9%) | −172.6 | −170.2 | 2.25 |
| BMI1 SRX7196721 | SF8628 Neural | 1589 / 14814 (10.7%) | 6980 / 148140 (4.7%) | −172.1 | −169.7 | 2.28 |
| SSRP1 SRX3436567 | HT-1080 Bone | 395 / 14814 (2.7%) | 485 / 148140 (0.3%) | −171.6 | −169.3 | 8.14 |
| ESR1 SRX20282954 | MCF-7 Breast | 303 / 14814 (2.0%) | 10886 / 148140 (7.3%) | −171.4 | −169.0 | 0.28 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 237 / 14814 (1.6%) | 9702 / 148140 (6.5%) | −170.8 | −168.5 | 0.24 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 414 / 14814 (2.8%) | 12716 / 148140 (8.6%) | −170.7 | −168.3 | 0.33 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 660 / 14814 (4.5%) | 1556 / 148140 (1.1%) | −170.7 | −168.3 | 4.24 |
| FOXA1 SRX1787653 | MCF-7 Breast | 211 / 14814 (1.4%) | 9207 / 148140 (6.2%) | −170.3 | −167.9 | 0.23 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 242 / 14814 (1.6%) | 9764 / 148140 (6.6%) | −169.9 | −167.6 | 0.25 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 474 / 14814 (3.2%) | 13632 / 148140 (9.2%) | −169.7 | −167.3 | 0.35 |
| MECOM SRX23677884 | HNT-34 Blood | 1603 / 14814 (10.8%) | 7129 / 148140 (4.8%) | −169.3 | −166.9 | 2.25 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1452 / 14814 (9.8%) | 6136 / 148140 (4.1%) | −168.9 | −166.6 | 2.37 |
| FOXA1 SRX100454 | T-47D Breast | 367 / 14814 (2.5%) | 11864 / 148140 (8.0%) | −168.2 | −165.9 | 0.31 |
| FOS SRX150517 | MCF 10A Breast | 504 / 14814 (3.4%) | 14022 / 148140 (9.5%) | −167.5 | −165.1 | 0.36 |
| MECOM SRX23677897 | HNT-34 Blood | 1878 / 14814 (12.7%) | 9066 / 148140 (6.1%) | −167.5 | −165.1 | 2.07 |
| AR SRX1067071 | LHSAR Prostate | 578 / 14814 (3.9%) | 15125 / 148140 (10.2%) | −166.6 | −164.3 | 0.38 |
| ESR1 SRX20282972 | MCF-7 Breast | 320 / 14814 (2.2%) | 11023 / 148140 (7.4%) | −166.5 | −164.2 | 0.29 |
| FOXA1 SRX371480 | MCF-7 Breast | 179 / 14814 (1.2%) | 8482 / 148140 (5.7%) | −166.4 | −164.1 | 0.21 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 490 / 14814 (3.3%) | 858 / 148140 (0.6%) | −165.9 | −163.5 | 5.71 |
| BMI1 SRX644729 | 293 Kidney | 246 / 14814 (1.7%) | 113 / 148140 (0.1%) | −165.8 | −163.5 | 21.77 |
| GATA3 SRX176864 | MCF-7 Breast | 195 / 14814 (1.3%) | 8770 / 148140 (5.9%) | −165.7 | −163.4 | 0.22 |
| FOXA1 SRX3923514 | MCF-7 Breast | 284 / 14814 (1.9%) | 10347 / 148140 (7.0%) | −164.8 | −162.4 | 0.27 |
| ESR1 SRX2943591 | MCF-7 Breast | 183 / 14814 (1.2%) | 8476 / 148140 (5.7%) | −163.6 | −161.2 | 0.22 |
| FOXA1 SRX3931043 | MCF-7 Breast | 282 / 14814 (1.9%) | 10268 / 148140 (6.9%) | −163.2 | −160.9 | 0.27 |
| RUNX1 SRX2014504 | Jurkat Blood | 2191 / 14814 (14.8%) | 11445 / 148140 (7.7%) | −162.9 | −160.6 | 1.91 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 113 / 14814 (0.8%) | 7032 / 148140 (4.7%) | −162.5 | −160.2 | 0.16 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 838 / 14814 (5.7%) | 2540 / 148140 (1.7%) | −162.3 | −160.0 | 3.30 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 278 / 14814 (1.9%) | 10154 / 148140 (6.9%) | −161.9 | −159.6 | 0.27 |
| AR SRX9469988 | LAPC-4 Prostate | 394 / 14814 (2.7%) | 12080 / 148140 (8.2%) | −161.5 | −159.2 | 0.33 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 380 / 14814 (2.6%) | 11852 / 148140 (8.0%) | −161.3 | −159.0 | 0.32 |
| TLE3 SRX4815192 | MCF-7 Breast | 251 / 14814 (1.7%) | 9660 / 148140 (6.5%) | −161.3 | −159.0 | 0.26 |
| FOXA1 SRX1161174 | MCF-7 Breast | 301 / 14814 (2.0%) | 10510 / 148140 (7.1%) | −160.6 | −158.3 | 0.29 |
| AR SRX1067070 | LHSAR Prostate | 741 / 14814 (5.0%) | 17285 / 148140 (11.7%) | −160.5 | −158.2 | 0.43 |
| MECOM SRX23677896 | HNT-34 Blood | 1921 / 14814 (13.0%) | 9545 / 148140 (6.4%) | −160.2 | −157.9 | 2.01 |
| ESR1 SRX20282955 | MCF-7 Breast | 307 / 14814 (2.1%) | 10581 / 148140 (7.1%) | −159.7 | −157.4 | 0.29 |
| ESR1 SRX371475 | BT-474 Breast | 122 / 14814 (0.8%) | 7138 / 148140 (4.8%) | −159.3 | −157.1 | 0.17 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 214 / 14814 (1.4%) | 8930 / 148140 (6.0%) | −159.2 | −156.9 | 0.24 |
| ESR1 SRX10365536 | MCF-7 Breast | 133 / 14814 (0.9%) | 7360 / 148140 (5.0%) | −159.1 | −156.8 | 0.18 |
| ESR1 SRX371477 | MCF-7 Breast | 123 / 14814 (0.8%) | 7146 / 148140 (4.8%) | −158.9 | −156.6 | 0.17 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 375 / 14814 (2.5%) | 11680 / 148140 (7.9%) | −158.7 | −156.4 | 0.32 |
| FOS SRX150476 | MCF 10A Breast | 530 / 14814 (3.6%) | 14097 / 148140 (9.5%) | −158.3 | −156.0 | 0.38 |
| GATA3 SRX5057632 | MCF-7 Breast | 182 / 14814 (1.2%) | 8265 / 148140 (5.6%) | −157.0 | −154.7 | 0.22 |
| JUNB SRX8488088 | SUM 229PE Breast | 595 / 14814 (4.0%) | 15021 / 148140 (10.1%) | −156.9 | −154.6 | 0.40 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 190 / 14814 (1.3%) | 8411 / 148140 (5.7%) | −156.8 | −154.5 | 0.23 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1639 / 14814 (11.1%) | 7641 / 148140 (5.2%) | −156.6 | −154.4 | 2.15 |
| ESR1 SRX20282946 | MCF-7 Breast | 161 / 14814 (1.1%) | 7844 / 148140 (5.3%) | −156.6 | −154.3 | 0.21 |
| RAC1 SRX10365543 | MCF-7 Breast | 138 / 14814 (0.9%) | 7377 / 148140 (5.0%) | −156.2 | −154.0 | 0.19 |
| ESR1 SRX20282973 | MCF-7 Breast | 363 / 14814 (2.5%) | 11401 / 148140 (7.7%) | −156.2 | −154.0 | 0.32 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 760 / 14814 (5.1%) | 2208 / 148140 (1.5%) | −155.2 | −152.9 | 3.44 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1617 / 14814 (10.9%) | 7536 / 148140 (5.1%) | −154.6 | −152.4 | 2.15 |
| RAC1 SRX10365541 | MCF-7 Breast | 140 / 14814 (0.9%) | 7372 / 148140 (5.0%) | −154.5 | −152.3 | 0.19 |
| FOXA1 SRX11222441 | MCF-7 Breast | 212 / 14814 (1.4%) | 8745 / 148140 (5.9%) | −154.3 | −152.1 | 0.24 |
| FOXA1 SRX11222437 | MCF-7 Breast | 202 / 14814 (1.4%) | 8545 / 148140 (5.8%) | −153.9 | −151.6 | 0.24 |
| ESR1 SRX20282940 | MCF-7 Breast | 329 / 14814 (2.2%) | 10753 / 148140 (7.3%) | −153.6 | −151.3 | 0.31 |
| KMT2A SRX2323891 | 293 Kidney | 914 / 14814 (6.2%) | 3075 / 148140 (2.1%) | −153.4 | −151.1 | 2.97 |
| ESR1 SRX371474 | BT-474 Breast | 115 / 14814 (0.8%) | 6820 / 148140 (4.6%) | −153.3 | −151.1 | 0.17 |
| ESR1 SRX2943589 | MCF-7 Breast | 131 / 14814 (0.9%) | 7150 / 148140 (4.8%) | −153.1 | −150.9 | 0.18 |
| FOXA1 SRX1787652 | MCF-7 Breast | 162 / 14814 (1.1%) | 7754 / 148140 (5.2%) | −152.7 | −150.5 | 0.21 |
| FOXA1 SRX100506 | Hep G2 Liver | 395 / 14814 (2.7%) | 11780 / 148140 (8.0%) | −152.1 | −149.9 | 0.34 |
| Epitope tags SRX10549778 | K-562 Blood | 1015 / 14814 (6.9%) | 3685 / 148140 (2.5%) | −152.0 | −149.8 | 2.75 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1604 / 14814 (10.8%) | 7504 / 148140 (5.1%) | −152.0 | −149.8 | 2.14 |
| ESR1 SRX4367192 | MCF-7 Breast | 643 / 14814 (4.3%) | 15526 / 148140 (10.5%) | −151.4 | −149.2 | 0.41 |
| FOXA1 SRX028634 | MCF-7 Breast | 126 / 14814 (0.9%) | 6999 / 148140 (4.7%) | −151.4 | −149.2 | 0.18 |
| ESR1 SRX10365535 | MCF-7 Breast | 235 / 14814 (1.6%) | 9065 / 148140 (6.1%) | −151.3 | −149.1 | 0.26 |
| FOXA2 SRX3230382 | Hep G2 Liver | 411 / 14814 (2.8%) | 12000 / 148140 (8.1%) | −151.1 | −148.8 | 0.34 |
| FOXA1 SRX11222442 | MCF-7 Breast | 184 / 14814 (1.2%) | 8121 / 148140 (5.5%) | −150.8 | −148.6 | 0.23 |
| RORC SRX5359052 | HCC70 Breast | 1180 / 14814 (8.0%) | 4717 / 148140 (3.2%) | −150.7 | −148.5 | 2.50 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 710 / 14814 (4.8%) | 1998 / 148140 (1.3%) | −150.6 | −148.4 | 3.55 |
| ARID1A SRX5089379 | MCF-7 Breast | 300 / 14814 (2.0%) | 10166 / 148140 (6.9%) | −150.5 | −148.3 | 0.30 |
| FOXA1 SRX3923517 | MCF-7 Breast | 201 / 14814 (1.4%) | 8417 / 148140 (5.7%) | −150.3 | −148.1 | 0.24 |
| EP300 SRX176885 | MCF-7 Breast | 138 / 14814 (0.9%) | 7207 / 148140 (4.9%) | −150.2 | −148.0 | 0.19 |
| ESR1 SRX2881002 | MCF-7 Breast | 282 / 14814 (1.9%) | 9852 / 148140 (6.7%) | −150.2 | −148.0 | 0.29 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 324 / 14814 (2.2%) | 10552 / 148140 (7.1%) | −150.0 | −147.8 | 0.31 |
| CDK9 SRX7366783 | MCF-7 Breast | 241 / 14814 (1.6%) | 140 / 148140 (0.1%) | −150.0 | −147.8 | 17.21 |
| ESR1 SRX2881000 | MCF-7 Breast | 262 / 14814 (1.8%) | 9502 / 148140 (6.4%) | −149.9 | −147.8 | 0.28 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1691 / 14814 (11.4%) | 8167 / 148140 (5.5%) | −149.4 | −147.2 | 2.07 |
| ESR1 SRX3110725 | MCF-7 Breast | 266 / 14814 (1.8%) | 9551 / 148140 (6.4%) | −149.4 | −147.2 | 0.28 |
| PGR SRX1012655 | MCF-7 Breast | 176 / 14814 (1.2%) | 7921 / 148140 (5.3%) | −149.2 | −147.0 | 0.22 |
| KAT7 DRX234808 | 293 Kidney | 720 / 14814 (4.9%) | 2066 / 148140 (1.4%) | −149.2 | −147.0 | 3.48 |
| FOXA1 SRX3931054 | MCF-7 Breast | 277 / 14814 (1.9%) | 9730 / 148140 (6.6%) | −149.1 | −146.9 | 0.28 |
| FOXA1 SRX1787655 | MCF-7 Breast | 131 / 14814 (0.9%) | 7031 / 148140 (4.7%) | −149.0 | −146.9 | 0.19 |
| RORC SRX5359053 | HCC70 Breast | 1146 / 14814 (7.7%) | 4535 / 148140 (3.1%) | −148.9 | −146.7 | 2.53 |
| JADE3 DRX300415 | 293 Kidney | 1365 / 14814 (9.2%) | 5952 / 148140 (4.0%) | −148.8 | −146.6 | 2.29 |
| EP300 SRX1012648 | MCF-7 Breast | 123 / 14814 (0.8%) | 6840 / 148140 (4.6%) | −148.0 | −145.9 | 0.18 |
| ESR1 SRX1012629 | MCF-7 Breast | 175 / 14814 (1.2%) | 7864 / 148140 (5.3%) | −147.9 | −145.8 | 0.22 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 411 / 14814 (2.8%) | 11893 / 148140 (8.0%) | −147.9 | −145.7 | 0.35 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 399 / 14814 (2.7%) | 11688 / 148140 (7.9%) | −147.5 | −145.4 | 0.34 |
| ESR1 SRX1012632 | MCF-7 Breast | 131 / 14814 (0.9%) | 6985 / 148140 (4.7%) | −147.5 | −145.3 | 0.19 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1119 / 14814 (7.6%) | 4396 / 148140 (3.0%) | −147.2 | −145.0 | 2.55 |
| NR2F2 SRX190293 | MCF-7 Breast | 324 / 14814 (2.2%) | 10459 / 148140 (7.1%) | −147.2 | −145.0 | 0.31 |
| FOXA1 SRX3931055 | MCF-7 Breast | 249 / 14814 (1.7%) | 9171 / 148140 (6.2%) | −146.7 | −144.6 | 0.27 |
| GATA3 SRX6712581 | MCF-7 Breast | 246 / 14814 (1.7%) | 9107 / 148140 (6.1%) | −146.4 | −144.3 | 0.27 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1831 / 14814 (12.4%) | 9245 / 148140 (6.2%) | −146.2 | −144.0 | 1.98 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 495 / 14814 (3.3%) | 1016 / 148140 (0.7%) | −146.2 | −144.0 | 4.87 |
| FOXA1 SRX5323843 | MCF-7 Breast | 141 / 14814 (1.0%) | 7142 / 148140 (4.8%) | −146.0 | −143.8 | 0.20 |
| ESR1 SRX8537722 | MCF-7 Breast | 282 / 14814 (1.9%) | 9708 / 148140 (6.6%) | −145.7 | −143.6 | 0.29 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 271 / 14814 (1.8%) | 9518 / 148140 (6.4%) | −145.7 | −143.5 | 0.28 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1268 / 14814 (8.6%) | 5375 / 148140 (3.6%) | −145.6 | −143.5 | 2.36 |
| ESR1 SRX330070 | MCF-7 Breast | 142 / 14814 (1.0%) | 7149 / 148140 (4.8%) | −145.5 | −143.4 | 0.20 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1209 / 14814 (8.2%) | 4995 / 148140 (3.4%) | −145.4 | −143.3 | 2.42 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 280 / 14814 (1.9%) | 9664 / 148140 (6.5%) | −145.3 | −143.2 | 0.29 |
| FOXA1 SRX3923516 | MCF-7 Breast | 210 / 14814 (1.4%) | 8431 / 148140 (5.7%) | −145.3 | −143.2 | 0.25 |
| FOXA1 SRX1787651 | MCF-7 Breast | 157 / 14814 (1.1%) | 7433 / 148140 (5.0%) | −145.2 | −143.0 | 0.21 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 278 / 14814 (1.9%) | 9619 / 148140 (6.5%) | −145.1 | −143.0 | 0.29 |
| ZEB1 SRX13298925 | MCF-7 Breast | 174 / 14814 (1.2%) | 7761 / 148140 (5.2%) | −145.1 | −143.0 | 0.22 |
| AR SRX1067066 | LHSAR Prostate | 673 / 14814 (4.5%) | 15706 / 148140 (10.6%) | −144.8 | −142.7 | 0.43 |
| ESR1 SRX330067 | MCF-7 Breast | 276 / 14814 (1.9%) | 9575 / 148140 (6.5%) | −144.8 | −142.6 | 0.29 |
| AR SRX1067067 | LHSAR Prostate | 535 / 14814 (3.6%) | 13679 / 148140 (9.2%) | −144.6 | −142.5 | 0.39 |
| FOXA2 SRX100448 | Hep G2 Liver | 336 / 14814 (2.3%) | 10569 / 148140 (7.1%) | −144.5 | −142.4 | 0.32 |
| CEBPA SRX2630241 | Hep G2 Liver | 370 / 14814 (2.5%) | 11124 / 148140 (7.5%) | −144.5 | −142.4 | 0.33 |
| FOXA1 SRX028635 | MCF-7 Breast | 135 / 14814 (0.9%) | 6964 / 148140 (4.7%) | −143.8 | −141.7 | 0.19 |
| FOXA1 SRX11222438 | MCF-7 Breast | 152 / 14814 (1.0%) | 7262 / 148140 (4.9%) | −142.6 | −140.5 | 0.21 |
| ESR1 SRX20282971 | MCF-7 Breast | 311 / 14814 (2.1%) | 10086 / 148140 (6.8%) | −142.4 | −140.2 | 0.31 |
| NFYB SRX16608147 | HeLa Uterus | 247 / 14814 (1.7%) | 175 / 148140 (0.1%) | −142.2 | −140.1 | 14.11 |
| ESR1 SRX1531796 | MCF-7 Breast | 155 / 14814 (1.0%) | 7302 / 148140 (4.9%) | −142.0 | −139.9 | 0.21 |
| FOXA1 SRX6878603 | LNCAP Prostate | 349 / 14814 (2.4%) | 10685 / 148140 (7.2%) | −141.6 | −139.4 | 0.33 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 673 / 14814 (4.5%) | 1910 / 148140 (1.3%) | −141.2 | −139.1 | 3.52 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 244 / 14814 (1.6%) | 8891 / 148140 (6.0%) | −140.7 | −138.6 | 0.27 |
| FOXA1 SRX1447317 | MCF-7 Breast | 192 / 14814 (1.3%) | 7952 / 148140 (5.4%) | −140.4 | −138.3 | 0.24 |
| FOXA1 SRX3923518 | MCF-7 Breast | 206 / 14814 (1.4%) | 8205 / 148140 (5.5%) | −140.4 | −138.2 | 0.25 |
| TET2 SRX1427029 | 293 Kidney | 1158 / 14814 (7.8%) | 4771 / 148140 (3.2%) | −139.9 | −137.8 | 2.43 |
| ESR1 SRX3123829 | MCF-7 Breast | 170 / 14814 (1.1%) | 7526 / 148140 (5.1%) | −139.8 | −137.7 | 0.23 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 300 / 14814 (2.0%) | 9818 / 148140 (6.6%) | −139.8 | −137.7 | 0.31 |
| ESR1 SRX20282953 | MCF-7 Breast | 257 / 14814 (1.7%) | 9077 / 148140 (6.1%) | −139.4 | −137.3 | 0.28 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1094 / 14814 (7.4%) | 4374 / 148140 (3.0%) | −139.3 | −137.2 | 2.50 |
| ESR1 SRX10365532 | MCF-7 Breast | 159 / 14814 (1.1%) | 7280 / 148140 (4.9%) | −138.7 | −136.6 | 0.22 |
| FOS SRX4192879 | MCF 10A Breast | 377 / 14814 (2.5%) | 11032 / 148140 (7.4%) | −138.6 | −136.5 | 0.34 |
| FOXA1 SRX3923519 | MCF-7 Breast | 182 / 14814 (1.2%) | 7707 / 148140 (5.2%) | −138.4 | −136.3 | 0.24 |
| ERG SRX063922 | K-562 Blood | 1379 / 14814 (9.3%) | 6257 / 148140 (4.2%) | −138.4 | −136.3 | 2.20 |
| CDK9 SRX7366781 | MCF-7 Breast | 224 / 14814 (1.5%) | 133 / 148140 (0.1%) | −138.3 | −136.2 | 16.84 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 959 / 14814 (6.5%) | 3563 / 148140 (2.4%) | −138.1 | −136.0 | 2.69 |
| SMARCA2 SRX8119677 | MeT-5A Others | 543 / 14814 (3.7%) | 13545 / 148140 (9.1%) | −137.8 | −135.7 | 0.40 |
| TEAD1 SRX3401272 | MCF-7 Breast | 236 / 14814 (1.6%) | 8659 / 148140 (5.8%) | −137.7 | −135.6 | 0.27 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 252 / 14814 (1.7%) | 8934 / 148140 (6.0%) | −137.6 | −135.5 | 0.28 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1113 / 14814 (7.5%) | 21399 / 148140 (14.4%) | −137.4 | −135.3 | 0.52 |
| ESR1 SRX20282938 | MCF-7 Breast | 253 / 14814 (1.7%) | 8945 / 148140 (6.0%) | −137.4 | −135.3 | 0.28 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 140 / 14814 (0.9%) | 6872 / 148140 (4.6%) | −137.4 | −135.3 | 0.20 |
| MethylCap SRX014767 | NB-4 Blood | 1513 / 14814 (10.2%) | 7201 / 148140 (4.9%) | −137.2 | −135.2 | 2.10 |
| FOXA1 SRX3931033 | MCF-7 Breast | 190 / 14814 (1.3%) | 7811 / 148140 (5.3%) | −136.9 | −134.8 | 0.24 |
| GRHL3 SRX2582162 | NHEK Epidermis | 941 / 14814 (6.4%) | 3475 / 148140 (2.3%) | −136.6 | −134.5 | 2.71 |
| ZFX SRX7805372 | 293 Kidney | 1370 / 14814 (9.2%) | 6239 / 148140 (4.2%) | −136.4 | −134.4 | 2.20 |
| ESR1 SRX1469949 | MCF-7 Breast | 173 / 14814 (1.2%) | 7472 / 148140 (5.0%) | −136.3 | −134.2 | 0.23 |
| FOXA1 SRX5203303 | MCF-7 Breast | 93 / 14814 (0.6%) | 5850 / 148140 (3.9%) | −135.3 | −133.2 | 0.16 |
| ESR1 SRX5323873 | MCF-7 Breast | 410 / 14814 (2.8%) | 11431 / 148140 (7.7%) | −135.2 | −133.1 | 0.36 |
| ESR1 SRX1012633 | MCF-7 Breast | 154 / 14814 (1.0%) | 7083 / 148140 (4.8%) | −135.2 | −133.1 | 0.22 |
| ESR1 SRX4451213 | MCF-7 Breast | 333 / 14814 (2.2%) | 10202 / 148140 (6.9%) | −135.0 | −132.9 | 0.33 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1371 / 14814 (9.3%) | 6276 / 148140 (4.2%) | −134.9 | −132.8 | 2.18 |
| ARID1A SRX5089382 | MCF-7 Breast | 224 / 14814 (1.5%) | 8355 / 148140 (5.6%) | −134.8 | −132.7 | 0.27 |
| FOS SRX3322636 | MCF-7 Breast | 205 / 14814 (1.4%) | 8003 / 148140 (5.4%) | −134.3 | −132.3 | 0.26 |
| ESR1 SRX330069 | MCF-7 Breast | 193 / 14814 (1.3%) | 7782 / 148140 (5.3%) | −134.2 | −132.1 | 0.25 |
| FOXA1 SRX1961158 | T-47D Breast | 320 / 14814 (2.2%) | 9955 / 148140 (6.7%) | −134.1 | −132.0 | 0.32 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 300 / 14814 (2.0%) | 9625 / 148140 (6.5%) | −134.0 | −132.0 | 0.31 |
| ESR1 SRX10365558 | MCF-7 Breast | 214 / 14814 (1.4%) | 8149 / 148140 (5.5%) | −134.0 | −131.9 | 0.26 |
| CEBPB SRX150632 | HeLa Uterus | 761 / 14814 (5.1%) | 16515 / 148140 (11.1%) | −134.0 | −131.9 | 0.46 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 229 / 14814 (1.5%) | 8408 / 148140 (5.7%) | −133.6 | −131.6 | 0.27 |
| ESR1 SRX8537723 | MCF-7 Breast | 262 / 14814 (1.8%) | 8974 / 148140 (6.1%) | −133.6 | −131.6 | 0.29 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 354 / 14814 (2.4%) | 10490 / 148140 (7.1%) | −133.5 | −131.5 | 0.34 |
| NR3C1 SRX19024866 | MCF-7 Breast | 97 / 14814 (0.7%) | 5887 / 148140 (4.0%) | −133.5 | −131.5 | 0.16 |
| SSRP1 SRX3436566 | HT-1080 Bone | 284 / 14814 (1.9%) | 305 / 148140 (0.2%) | −133.5 | −131.5 | 9.31 |
| ESR1 SRX10365533 | MCF-7 Breast | 145 / 14814 (1.0%) | 6855 / 148140 (4.6%) | −133.4 | −131.4 | 0.21 |
| AR SRX9109110 | MDA-MB-453 Breast | 634 / 14814 (4.3%) | 14694 / 148140 (9.9%) | −133.2 | −131.1 | 0.43 |
| TET2 SRX2014505 | Jurkat Blood | 2272 / 14814 (15.3%) | 12915 / 148140 (8.7%) | −133.0 | −131.0 | 1.76 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1381 / 14814 (9.3%) | 6385 / 148140 (4.3%) | −133.0 | −131.0 | 2.16 |
| EP300 SRX1012644 | MCF-7 Breast | 135 / 14814 (0.9%) | 6645 / 148140 (4.5%) | −133.0 | −130.9 | 0.20 |
| CEBPA SRX4705113 | MOLM-13 Blood | 764 / 14814 (5.2%) | 16513 / 148140 (11.1%) | −132.9 | −130.8 | 0.46 |
| EP300 SRX176883 | MCF-7 Breast | 142 / 14814 (1.0%) | 6760 / 148140 (4.6%) | −132.2 | −130.2 | 0.21 |
| MEN1 SRX11712604 | K-562 Blood | 1231 / 14814 (8.3%) | 5394 / 148140 (3.6%) | −132.2 | −130.2 | 2.28 |
| FOXA1 SRX1961157 | T-47D Breast | 358 / 14814 (2.4%) | 10498 / 148140 (7.1%) | −132.0 | −130.0 | 0.34 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 313 / 14814 (2.1%) | 9765 / 148140 (6.6%) | −131.8 | −129.8 | 0.32 |
| CEBPB SRX190345 | MCF-7 Breast | 250 / 14814 (1.7%) | 8709 / 148140 (5.9%) | −131.8 | −129.7 | 0.29 |
| ERG SRX063921 | K-562 Blood | 1302 / 14814 (8.8%) | 5876 / 148140 (4.0%) | −131.7 | −129.7 | 2.22 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 491 / 14814 (3.3%) | 12543 / 148140 (8.5%) | −131.7 | −129.6 | 0.39 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 588 / 14814 (4.0%) | 13964 / 148140 (9.4%) | −131.5 | −129.5 | 0.42 |
| TFAP2C SRX018833 | MCF-7 Breast | 303 / 14814 (2.0%) | 9588 / 148140 (6.5%) | −131.4 | −129.4 | 0.32 |
| FOXA1 SRX100477 | Hep G2 Liver | 373 / 14814 (2.5%) | 10715 / 148140 (7.2%) | −131.3 | −129.2 | 0.35 |
| ESR1 SRX20282959 | MCF-7 Breast | 127 / 14814 (0.9%) | 6436 / 148140 (4.3%) | −131.2 | −129.2 | 0.20 |
| YAP1 SRX5718140 | 293 Kidney | 579 / 14814 (3.9%) | 13816 / 148140 (9.3%) | −131.0 | −129.0 | 0.42 |
| ARID1A SRX5089391 | MCF-7 Breast | 177 / 14814 (1.2%) | 7389 / 148140 (5.0%) | −131.0 | −129.0 | 0.24 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 815 / 14814 (5.5%) | 17131 / 148140 (11.6%) | −130.8 | −128.8 | 0.48 |
| ESR1 SRX2912055 | MCF-7 Breast | 115 / 14814 (0.8%) | 6177 / 148140 (4.2%) | −130.7 | −128.6 | 0.19 |
| TFAP2C SRX128099 | MCF-7 Breast | 305 / 14814 (2.1%) | 9582 / 148140 (6.5%) | −130.3 | −128.3 | 0.32 |
| CXXC1 SRX1424886 | SEM Blood | 1261 / 14814 (8.5%) | 5631 / 148140 (3.8%) | −130.3 | −128.3 | 2.24 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 292 / 14814 (2.0%) | 9370 / 148140 (6.3%) | −130.3 | −128.2 | 0.31 |
| NR3C1 SRX17639412 | A549 Lung | 369 / 14814 (2.5%) | 10606 / 148140 (7.2%) | −130.1 | −128.1 | 0.35 |
| STAT3 SRX2020842 | HCC70 Breast | 602 / 14814 (4.1%) | 14111 / 148140 (9.5%) | −130.0 | −128.0 | 0.43 |
| ARID5B SRX3230377 | Hep G2 Liver | 839 / 14814 (5.7%) | 17423 / 148140 (11.8%) | −130.0 | −127.9 | 0.48 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 309 / 14814 (2.1%) | 9634 / 148140 (6.5%) | −129.8 | −127.8 | 0.32 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 211 / 14814 (1.4%) | 7965 / 148140 (5.4%) | −129.7 | −127.7 | 0.26 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 109 / 14814 (0.7%) | 6030 / 148140 (4.1%) | −129.7 | −127.7 | 0.18 |
| FOXA1 SRX15430999 | T-47D Breast | 373 / 14814 (2.5%) | 10655 / 148140 (7.2%) | −129.7 | −127.7 | 0.35 |
| FOXA1 SRX9604647 | LNCAP Prostate | 510 / 14814 (3.4%) | 12745 / 148140 (8.6%) | −129.6 | −127.6 | 0.40 |
| GATA3 SRX5457550 | MCF-7 Breast | 383 / 14814 (2.6%) | 10807 / 148140 (7.3%) | −129.5 | −127.5 | 0.35 |
| MECOM SRX23677890 | HNT-34 Blood | 1556 / 14814 (10.5%) | 7696 / 148140 (5.2%) | −129.3 | −127.3 | 2.02 |
| FOXA1 SRX3923515 | MCF-7 Breast | 177 / 14814 (1.2%) | 7332 / 148140 (4.9%) | −129.2 | −127.2 | 0.24 |
| ESR1 SRX1012630 | MCF-7 Breast | 116 / 14814 (0.8%) | 6146 / 148140 (4.1%) | −128.8 | −126.8 | 0.19 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 353 / 14814 (2.4%) | 10310 / 148140 (7.0%) | −128.8 | −126.8 | 0.34 |
| FOXA1 SRX1787654 | MCF-7 Breast | 109 / 14814 (0.7%) | 6004 / 148140 (4.1%) | −128.8 | −126.8 | 0.18 |
| FOXA1 SRX9604645 | LNCAP Prostate | 475 / 14814 (3.2%) | 12193 / 148140 (8.2%) | −128.7 | −126.7 | 0.39 |
| JUN SRX4192884 | MCF 10A Breast | 283 / 14814 (1.9%) | 9167 / 148140 (6.2%) | −128.6 | −126.6 | 0.31 |
| STAT1 SRX23678708 | K-562 Blood | 1317 / 14814 (8.9%) | 6045 / 148140 (4.1%) | −128.6 | −126.6 | 2.18 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 214 / 14814 (1.4%) | 7982 / 148140 (5.4%) | −128.6 | −126.6 | 0.27 |
| RBFOX2 SRX4708082 | K-562 Blood | 2025 / 14814 (13.7%) | 11168 / 148140 (7.5%) | −128.4 | −126.4 | 1.81 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 797 / 14814 (5.4%) | 16786 / 148140 (11.3%) | −128.4 | −126.4 | 0.47 |
| FOXA1 SRX5323845 | MCF-7 Breast | 110 / 14814 (0.7%) | 6009 / 148140 (4.1%) | −128.3 | −126.4 | 0.18 |
| AR SRX9109113 | MDA-MB-453 Breast | 660 / 14814 (4.5%) | 14870 / 148140 (10.0%) | −128.3 | −126.3 | 0.44 |
| FOXA1 SRX1447316 | MCF-7 Breast | 130 / 14814 (0.9%) | 6406 / 148140 (4.3%) | −128.1 | −126.1 | 0.20 |
| ZEB1 SRX13298924 | MCF-7 Breast | 150 / 14814 (1.0%) | 6792 / 148140 (4.6%) | −128.1 | −126.1 | 0.22 |
| FOXA1 SRX219284 | LNCAP Prostate | 453 / 14814 (3.1%) | 11831 / 148140 (8.0%) | −128.0 | −126.0 | 0.38 |
| ARID1A SRX5089385 | MCF-7 Breast | 251 / 14814 (1.7%) | 8594 / 148140 (5.8%) | −127.7 | −125.8 | 0.29 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1218 / 14814 (8.2%) | 22317 / 148140 (15.1%) | −127.7 | −125.7 | 0.55 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1425 / 14814 (9.6%) | 6811 / 148140 (4.6%) | −127.7 | −125.7 | 2.09 |
| ESR1 SRX330068 | MCF-7 Breast | 154 / 14814 (1.0%) | 6838 / 148140 (4.6%) | −127.1 | −125.1 | 0.23 |
| JUNB SRX8488089 | SUM 229PE Breast | 342 / 14814 (2.3%) | 10072 / 148140 (6.8%) | −127.1 | −125.1 | 0.34 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 317 / 14814 (2.1%) | 9671 / 148140 (6.5%) | −127.1 | −125.1 | 0.33 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 825 / 14814 (5.6%) | 17102 / 148140 (11.5%) | −126.9 | −124.9 | 0.48 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 222 / 14814 (1.5%) | 8067 / 148140 (5.4%) | −126.9 | −124.9 | 0.28 |
| ESR1 SRX1469951 | MCF-7 Breast | 167 / 14814 (1.1%) | 7072 / 148140 (4.8%) | −126.6 | −124.7 | 0.24 |
| GATAD2A SRX2636506 | Hep G2 Liver | 436 / 14814 (2.9%) | 11518 / 148140 (7.8%) | −126.5 | −124.5 | 0.38 |
| FOXA1 SRX6878604 | LNCAP Prostate | 272 / 14814 (1.8%) | 8905 / 148140 (6.0%) | −126.4 | −124.4 | 0.31 |
| FOXA1 SRX1161203 | T-47D Breast | 237 / 14814 (1.6%) | 8312 / 148140 (5.6%) | −126.4 | −124.4 | 0.29 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1136 / 14814 (7.7%) | 21198 / 148140 (14.3%) | −126.4 | −124.4 | 0.54 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 180 / 14814 (1.2%) | 7300 / 148140 (4.9%) | −126.3 | −124.3 | 0.25 |
| FOXA1 SRX3931056 | MCF-7 Breast | 190 / 14814 (1.3%) | 7473 / 148140 (5.0%) | −126.1 | −124.1 | 0.25 |
| JADE3 DRX234809 | 293 Kidney | 888 / 14814 (6.0%) | 3328 / 148140 (2.2%) | −125.8 | −123.8 | 2.67 |
| SOX13 SRX2636248 | Hep G2 Liver | 472 / 14814 (3.2%) | 12032 / 148140 (8.1%) | −125.7 | −123.7 | 0.39 |
| FOXA1 SRX6860635 | T-47D Breast | 249 / 14814 (1.7%) | 8494 / 148140 (5.7%) | −125.7 | −123.7 | 0.29 |
| RELA SRX5938177 | FaDu Others | 315 / 14814 (2.1%) | 9589 / 148140 (6.5%) | −125.6 | −123.6 | 0.33 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1306 / 14814 (8.8%) | 6046 / 148140 (4.1%) | −125.1 | −123.2 | 2.16 |
| ING2 SRX286201 | RKO Digestive tract | 1214 / 14814 (8.2%) | 5425 / 148140 (3.7%) | −125.1 | −123.1 | 2.24 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1620 / 14814 (10.9%) | 8262 / 148140 (5.6%) | −124.9 | −122.9 | 1.96 |
| VGLL1 SRX24602130 | BT-20 Breast | 364 / 14814 (2.5%) | 10346 / 148140 (7.0%) | −124.8 | −122.9 | 0.35 |
| JUNB SRX10119386 | MCF 10A Breast | 315 / 14814 (2.1%) | 9558 / 148140 (6.5%) | −124.8 | −122.8 | 0.33 |
| NKX2-1 SRX2164786 | A549 Lung | 567 / 14814 (3.8%) | 13393 / 148140 (9.0%) | −124.6 | −122.6 | 0.42 |
| ESR1 SRX3110720 | MCF-7 Breast | 131 / 14814 (0.9%) | 6319 / 148140 (4.3%) | −124.4 | −122.5 | 0.21 |
| ARID1A SRX5089388 | MCF-7 Breast | 167 / 14814 (1.1%) | 7000 / 148140 (4.7%) | −124.4 | −122.5 | 0.24 |
| ESR1 SRX5323878 | MCF-7 Breast | 354 / 14814 (2.4%) | 10168 / 148140 (6.9%) | −124.3 | −122.4 | 0.35 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 137 / 14814 (0.9%) | 6430 / 148140 (4.3%) | −124.3 | −122.3 | 0.21 |
| MECOM SRX23677891 | HNT-34 Blood | 1535 / 14814 (10.4%) | 7676 / 148140 (5.2%) | −124.0 | −122.0 | 2.00 |
| EP300 SRX1012643 | MCF-7 Breast | 114 / 14814 (0.8%) | 5963 / 148140 (4.0%) | −123.9 | −122.0 | 0.19 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 218 / 14814 (1.5%) | 7900 / 148140 (5.3%) | −123.9 | −121.9 | 0.28 |
| ESR1 SRX1012628 | MCF-7 Breast | 168 / 14814 (1.1%) | 7001 / 148140 (4.7%) | −123.7 | −121.8 | 0.24 |
| FOXA1 SRX3931032 | MCF-7 Breast | 190 / 14814 (1.3%) | 7397 / 148140 (5.0%) | −123.6 | −121.7 | 0.26 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 746 / 14814 (5.0%) | 2524 / 148140 (1.7%) | −123.6 | −121.7 | 2.96 |
| ESR1 SRX5323872 | MCF-7 Breast | 354 / 14814 (2.4%) | 10140 / 148140 (6.8%) | −123.5 | −121.6 | 0.35 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 311 / 14814 (2.1%) | 9448 / 148140 (6.4%) | −123.4 | −121.5 | 0.33 |
| FOXA1 SRX5203294 | MCF-7 Breast | 89 / 14814 (0.6%) | 5426 / 148140 (3.7%) | −123.3 | −121.4 | 0.16 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 82 / 14814 (0.6%) | 5259 / 148140 (3.6%) | −122.8 | −120.8 | 0.16 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 747 / 14814 (5.0%) | 15859 / 148140 (10.7%) | −122.7 | −120.8 | 0.47 |
| AR SRX11149848 | MDA-MB-453 Breast | 215 / 14814 (1.5%) | 7810 / 148140 (5.3%) | −122.7 | −120.8 | 0.28 |
| FOXA1 SRX5203307 | MCF-7 Breast | 90 / 14814 (0.6%) | 5430 / 148140 (3.7%) | −122.7 | −120.8 | 0.17 |
| AR SRX15946405 | MDA-MB-453 Breast | 215 / 14814 (1.5%) | 7803 / 148140 (5.3%) | −122.4 | −120.5 | 0.28 |
| NR3C1 SRX19024870 | MCF-7 Breast | 105 / 14814 (0.7%) | 5737 / 148140 (3.9%) | −122.4 | −120.5 | 0.18 |
| FOXA1 SRX3923511 | MCF-7 Breast | 120 / 14814 (0.8%) | 6041 / 148140 (4.1%) | −122.4 | −120.5 | 0.20 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 365 / 14814 (2.5%) | 10272 / 148140 (6.9%) | −122.3 | −120.4 | 0.36 |
| SMARCA4 SRX5212366 | Mel270 Others | 473 / 14814 (3.2%) | 11920 / 148140 (8.0%) | −122.3 | −120.3 | 0.40 |
| JUNB SRX8488073 | SUM 229PE Breast | 664 / 14814 (4.5%) | 14676 / 148140 (9.9%) | −122.1 | −120.2 | 0.45 |
| ESR1 SRX5323877 | MCF-7 Breast | 277 / 14814 (1.9%) | 8840 / 148140 (6.0%) | −122.0 | −120.0 | 0.31 |
| ESR1 SRX1012631 | MCF-7 Breast | 146 / 14814 (1.0%) | 6532 / 148140 (4.4%) | −121.9 | −120.0 | 0.22 |
| PROX1 SRX3230397 | Hep G2 Liver | 245 / 14814 (1.7%) | 8295 / 148140 (5.6%) | −121.7 | −119.8 | 0.30 |
| FOXA1 SRX5323829 | T-47D Breast | 185 / 14814 (1.2%) | 7243 / 148140 (4.9%) | −121.6 | −119.6 | 0.26 |
| Epitope tags SRX10549777 | K-562 Blood | 2058 / 14814 (13.9%) | 11632 / 148140 (7.9%) | −121.4 | −119.5 | 1.77 |
| ESR1 SRX5323871 | MCF-7 Breast | 390 / 14814 (2.6%) | 10624 / 148140 (7.2%) | −121.3 | −119.4 | 0.37 |
| JUN SRX17561461 | LPS141 Adipocyte | 520 / 14814 (3.5%) | 12582 / 148140 (8.5%) | −121.3 | −119.4 | 0.41 |
| ESR1 SRX20282966 | MCF-7 Breast | 116 / 14814 (0.8%) | 5926 / 148140 (4.0%) | −121.2 | −119.3 | 0.20 |
| AR SRX9468654 | LNCAP Prostate | 395 / 14814 (2.7%) | 10685 / 148140 (7.2%) | −120.8 | −118.9 | 0.37 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 359 / 14814 (2.4%) | 10113 / 148140 (6.8%) | −120.6 | −118.7 | 0.35 |
| ZEB1 SRX13298923 | MCF-7 Breast | 141 / 14814 (1.0%) | 6397 / 148140 (4.3%) | −120.6 | −118.6 | 0.22 |
| AR SRX9468663 | LNCAP Prostate | 407 / 14814 (2.7%) | 10859 / 148140 (7.3%) | −120.5 | −118.6 | 0.37 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 687 / 14814 (4.6%) | 14927 / 148140 (10.1%) | −120.3 | −118.4 | 0.46 |
| HMG20A SRX2630163 | Hep G2 Liver | 190 / 14814 (1.3%) | 7285 / 148140 (4.9%) | −120.1 | −118.2 | 0.26 |
| FOXA1 SRX2017929 | LNCAP Prostate | 464 / 14814 (3.1%) | 11689 / 148140 (7.9%) | −119.7 | −117.8 | 0.40 |
| GRHL3 SRX2582161 | NHEK Epidermis | 776 / 14814 (5.2%) | 2752 / 148140 (1.9%) | −119.7 | −117.7 | 2.82 |
| ESR1 SRX4451212 | MCF-7 Breast | 334 / 14814 (2.3%) | 9668 / 148140 (6.5%) | −119.2 | −117.3 | 0.35 |
| NABP2 SRX9523535 | HT-1080 Bone | 1166 / 14814 (7.9%) | 5228 / 148140 (3.5%) | −119.0 | −117.1 | 2.23 |
| ESR1 SRX5323874 | MCF-7 Breast | 211 / 14814 (1.4%) | 7625 / 148140 (5.1%) | −119.0 | −117.1 | 0.28 |
| GATA3 SRX190194 | SK-N-SH Neural | 841 / 14814 (5.7%) | 16979 / 148140 (11.5%) | −119.0 | −117.1 | 0.50 |
| ESR1 SRX11120903 | MCF-7 Breast | 309 / 14814 (2.1%) | 9263 / 148140 (6.3%) | −119.0 | −117.1 | 0.33 |
| ESR1 SRX2513521 | MCF-7 Breast | 165 / 14814 (1.1%) | 6794 / 148140 (4.6%) | −118.9 | −117.0 | 0.24 |
| AR SRX9468664 | LNCAP Prostate | 499 / 14814 (3.4%) | 12177 / 148140 (8.2%) | −118.9 | −117.0 | 0.41 |
| MYC SRX13134693 | 293 Kidney | 1117 / 14814 (7.5%) | 4907 / 148140 (3.3%) | −118.8 | −116.9 | 2.28 |
| VGLL1 SRX18013277 | FULVR Breast | 142 / 14814 (1.0%) | 6361 / 148140 (4.3%) | −118.8 | −116.9 | 0.22 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 295 / 14814 (2.0%) | 9027 / 148140 (6.1%) | −118.7 | −116.8 | 0.33 |
| AR SRX1067068 | LHSAR Prostate | 424 / 14814 (2.9%) | 11047 / 148140 (7.5%) | −118.6 | −116.7 | 0.38 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1048 / 14814 (7.1%) | 4461 / 148140 (3.0%) | −118.5 | −116.6 | 2.35 |
| ESR1 SRX3110723 | MCF-7 Breast | 193 / 14814 (1.3%) | 7283 / 148140 (4.9%) | −118.3 | −116.4 | 0.27 |
| FOXA1 SRX5323846 | MCF-7 Breast | 124 / 14814 (0.8%) | 5998 / 148140 (4.0%) | −118.3 | −116.4 | 0.21 |
| ESR1 SRX792933 | LY2 Breast | 289 / 14814 (2.0%) | 8912 / 148140 (6.0%) | −118.3 | −116.4 | 0.32 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 104 / 14814 (0.7%) | 5596 / 148140 (3.8%) | −118.2 | −116.3 | 0.19 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 298 / 14814 (2.0%) | 9055 / 148140 (6.1%) | −118.2 | −116.3 | 0.33 |
| Epitope tags SRX2255894 | 293 Kidney | 1139 / 14814 (7.7%) | 5070 / 148140 (3.4%) | −118.0 | −116.1 | 2.25 |
| ARID5B SRX10475139 | Hep G2 Liver | 384 / 14814 (2.6%) | 10414 / 148140 (7.0%) | −118.0 | −116.1 | 0.37 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 805 / 14814 (5.4%) | 16451 / 148140 (11.1%) | −118.0 | −116.1 | 0.49 |
| ESR1 SRX1012625 | MCF-7 Breast | 184 / 14814 (1.2%) | 7111 / 148140 (4.8%) | −118.0 | −116.1 | 0.26 |
| ESR1 SRX2881001 | MCF-7 Breast | 196 / 14814 (1.3%) | 7315 / 148140 (4.9%) | −117.6 | −115.7 | 0.27 |
| ESR1 SRX176856 | MCF-7 Breast | 118 / 14814 (0.8%) | 5854 / 148140 (4.0%) | −117.4 | −115.5 | 0.20 |
| AFF1 SRX2281250 | SEM Blood | 826 / 14814 (5.6%) | 3086 / 148140 (2.1%) | −117.4 | −115.5 | 2.68 |
| FOXA1 SRX2642368 | VCaP Prostate | 437 / 14814 (2.9%) | 11197 / 148140 (7.6%) | −117.4 | −115.5 | 0.39 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1334 / 14814 (9.0%) | 23286 / 148140 (15.7%) | −117.3 | −115.4 | 0.57 |
| FOXA1 SRX3931073 | MCF-7 Breast | 206 / 14814 (1.4%) | 7479 / 148140 (5.0%) | −117.2 | −115.4 | 0.28 |
| FOXA1 SRX1161205 | T-47D Breast | 184 / 14814 (1.2%) | 7087 / 148140 (4.8%) | −117.2 | −115.4 | 0.26 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 489 / 14814 (3.3%) | 1237 / 148140 (0.8%) | −117.0 | −115.1 | 3.95 |
| MED1 SRX5236337 | HUVEC Cardiovascular | 496 / 14814 (3.3%) | 1271 / 148140 (0.9%) | −117.0 | −115.1 | 3.90 |
| FOXA1 SRX9604646 | LNCAP Prostate | 492 / 14814 (3.3%) | 12002 / 148140 (8.1%) | −117.0 | −115.1 | 0.41 |
| INTS3 SRX3640569 | HeLa Uterus | 1073 / 14814 (7.2%) | 4662 / 148140 (3.1%) | −116.6 | −114.7 | 2.30 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 189 / 14814 (1.3%) | 113 / 148140 (0.1%) | −116.5 | −114.6 | 16.73 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 177 / 14814 (1.2%) | 88 / 148140 (0.1%) | −116.5 | −114.6 | 20.11 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 434 / 14814 (2.9%) | 11113 / 148140 (7.5%) | −116.3 | −114.4 | 0.39 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1347 / 14814 (9.1%) | 6531 / 148140 (4.4%) | −116.3 | −114.4 | 2.06 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 300 / 14814 (2.0%) | 9024 / 148140 (6.1%) | −116.2 | −114.3 | 0.33 |
| NCOA3 SRX4663589 | MCF-7 Breast | 93 / 14814 (0.6%) | 5302 / 148140 (3.6%) | −115.9 | −114.1 | 0.18 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 279 / 14814 (1.9%) | 8666 / 148140 (5.8%) | −115.9 | −114.0 | 0.32 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 363 / 14814 (2.5%) | 10007 / 148140 (6.8%) | −115.8 | −114.0 | 0.36 |
| FOXA1 SRX219285 | LNCAP Prostate | 334 / 14814 (2.3%) | 9550 / 148140 (6.4%) | −115.7 | −113.8 | 0.35 |
| SOX5 SRX2636544 | Hep G2 Liver | 354 / 14814 (2.4%) | 9860 / 148140 (6.7%) | −115.7 | −113.8 | 0.36 |
| SREBF2 SRX5359049 | HCC70 Breast | 1003 / 14814 (6.8%) | 4225 / 148140 (2.9%) | −115.6 | −113.7 | 2.37 |
| FOXA1 SRX3923513 | MCF-7 Breast | 98 / 14814 (0.7%) | 5395 / 148140 (3.6%) | −115.6 | −113.7 | 0.18 |
| TRPS1 SRX3401273 | MCF-7 Breast | 115 / 14814 (0.8%) | 5736 / 148140 (3.9%) | −115.5 | −113.6 | 0.20 |
| FOXA2 SRX10475773 | Hep G2 Liver | 436 / 14814 (2.9%) | 11112 / 148140 (7.5%) | −115.4 | −113.6 | 0.39 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 422 / 14814 (2.8%) | 10894 / 148140 (7.4%) | −115.2 | −113.4 | 0.39 |
| ESR1 SRX5323876 | MCF-7 Breast | 191 / 14814 (1.3%) | 7152 / 148140 (4.8%) | −115.2 | −113.4 | 0.27 |
| NANOG SRX10445309 | Neural crest cells Neural | 197 / 14814 (1.3%) | 7256 / 148140 (4.9%) | −115.2 | −113.4 | 0.27 |
| MethylCap SRX014766 | NB-4 Blood | 1312 / 14814 (8.9%) | 6312 / 148140 (4.3%) | −115.2 | −113.3 | 2.08 |
| ESR1 SRX2513520 | MCF-7 Breast | 225 / 14814 (1.5%) | 7742 / 148140 (5.2%) | −115.2 | −113.3 | 0.29 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 422 / 14814 (2.8%) | 10889 / 148140 (7.4%) | −115.1 | −113.3 | 0.39 |
| MAU2 SRX11120893 | MCF-7 Breast | 141 / 14814 (1.0%) | 6226 / 148140 (4.2%) | −115.0 | −113.1 | 0.23 |
| STAT1 SRX23678707 | K-562 Blood | 1199 / 14814 (8.1%) | 5542 / 148140 (3.7%) | −114.8 | −112.9 | 2.16 |
| FOXA1 SRX2017928 | LNCAP Prostate | 422 / 14814 (2.8%) | 10875 / 148140 (7.3%) | −114.7 | −112.9 | 0.39 |
| KDM6A SRX15826236 | MCF-7 Breast | 111 / 14814 (0.7%) | 5636 / 148140 (3.8%) | −114.7 | −112.8 | 0.20 |
| FOS SRX3322637 | MCF-7 Breast | 194 / 14814 (1.3%) | 7184 / 148140 (4.8%) | −114.7 | −112.8 | 0.27 |
| ESR1 SRX2513517 | MCF-7 Breast | 247 / 14814 (1.7%) | 8095 / 148140 (5.5%) | −114.6 | −112.8 | 0.31 |
| FOXA1 SRX5323830 | T-47D Breast | 212 / 14814 (1.4%) | 7496 / 148140 (5.1%) | −114.6 | −112.7 | 0.28 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 703 / 14814 (4.7%) | 14904 / 148140 (10.1%) | −114.5 | −112.6 | 0.47 |
| ESR1 SRX5534831 | MCF-7 Breast | 282 / 14814 (1.9%) | 8662 / 148140 (5.8%) | −114.3 | −112.5 | 0.33 |
| FOXA1 SRX3931031 | MCF-7 Breast | 166 / 14814 (1.1%) | 6670 / 148140 (4.5%) | −114.3 | −112.4 | 0.25 |
| CHD6 SRX17709200 | C4-2 Prostate | 1312 / 14814 (8.9%) | 6338 / 148140 (4.3%) | −114.2 | −112.3 | 2.07 |
| AHR SRX20282969 | MCF-7 Breast | 170 / 14814 (1.1%) | 6741 / 148140 (4.6%) | −114.1 | −112.3 | 0.25 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 345 / 14814 (2.3%) | 9658 / 148140 (6.5%) | −114.0 | −112.1 | 0.36 |
| FOXA1 SRX3923508 | MCF-7 Breast | 106 / 14814 (0.7%) | 5505 / 148140 (3.7%) | −113.7 | −111.9 | 0.19 |
| KMT2C SRX1787675 | MCF-7 Breast | 330 / 14814 (2.2%) | 9415 / 148140 (6.4%) | −113.7 | −111.9 | 0.35 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 348 / 14814 (2.3%) | 9690 / 148140 (6.5%) | −113.6 | −111.7 | 0.36 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 167 / 14814 (1.1%) | 75 / 148140 (0.1%) | −113.5 | −111.7 | 22.27 |
| GATA3 SRX100559 | T-47D Breast | 401 / 14814 (2.7%) | 10509 / 148140 (7.1%) | −113.5 | −111.6 | 0.38 |
| NR3C1 SRX1161167 | MCF-7 Breast | 87 / 14814 (0.6%) | 5098 / 148140 (3.4%) | −113.2 | −111.4 | 0.17 |
| ESR1 SRX1469950 | MCF-7 Breast | 129 / 14814 (0.9%) | 5939 / 148140 (4.0%) | −113.1 | −111.2 | 0.22 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 300 / 14814 (2.0%) | 8909 / 148140 (6.0%) | −113.0 | −111.1 | 0.34 |
| FOXA1 SRX1161207 | T-47D Breast | 145 / 14814 (1.0%) | 6240 / 148140 (4.2%) | −112.8 | −111.0 | 0.23 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 1039 / 14814 (7.0%) | 4515 / 148140 (3.0%) | −112.7 | −110.9 | 2.30 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 319 / 14814 (2.2%) | 9203 / 148140 (6.2%) | −112.7 | −110.9 | 0.35 |
| Epitope tags SRX2867680 | 293 Kidney | 1717 / 14814 (11.6%) | 9316 / 148140 (6.3%) | −112.6 | −110.7 | 1.84 |
| ESR1 SRX371446 | Tumour tissues Others | 391 / 14814 (2.6%) | 10318 / 148140 (7.0%) | −112.5 | −110.6 | 0.38 |
| SS18 SRX3468047 | Fibroblasts Others | 910 / 14814 (6.1%) | 17603 / 148140 (11.9%) | −112.3 | −110.5 | 0.52 |
| GATAD2A SRX2636507 | Hep G2 Liver | 392 / 14814 (2.6%) | 10323 / 148140 (7.0%) | −112.2 | −110.4 | 0.38 |
| EP300 SRX100544 | Hep G2 Liver | 275 / 14814 (1.9%) | 8474 / 148140 (5.7%) | −112.1 | −110.3 | 0.32 |
| CHD6 SRX17709201 | C4-2 Prostate | 1264 / 14814 (8.5%) | 6064 / 148140 (4.1%) | −111.6 | −109.8 | 2.08 |
| SMARCA4 SRX5212362 | Mel270 Others | 630 / 14814 (4.3%) | 13766 / 148140 (9.3%) | −111.6 | −109.7 | 0.46 |
| NR3C1 SRX19024880 | MCF-7 Breast | 86 / 14814 (0.6%) | 5028 / 148140 (3.4%) | −111.5 | −109.6 | 0.17 |
| ESR1 SRX10365534 | MCF-7 Breast | 104 / 14814 (0.7%) | 5399 / 148140 (3.6%) | −111.3 | −109.5 | 0.19 |
| KDM5A SRX23740431 | SUM 149PT Breast | 1230 / 14814 (8.3%) | 5836 / 148140 (3.9%) | −111.2 | −109.3 | 2.11 |
| AHR SRX2378695 | MCF-7 Breast | 161 / 14814 (1.1%) | 6479 / 148140 (4.4%) | −111.1 | −109.2 | 0.25 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 938 / 14814 (6.3%) | 17907 / 148140 (12.1%) | −110.8 | −109.0 | 0.52 |
| AR SRX9468662 | LNCAP Prostate | 386 / 14814 (2.6%) | 10178 / 148140 (6.9%) | −110.8 | −108.9 | 0.38 |
| FOXA1 SRX3923510 | MCF-7 Breast | 135 / 14814 (0.9%) | 5986 / 148140 (4.0%) | −110.7 | −108.9 | 0.23 |
| FOXA1 SRX497612 | VCaP Prostate | 351 / 14814 (2.4%) | 9634 / 148140 (6.5%) | −110.7 | −108.9 | 0.36 |
| FOXA1 SRX1885181 | LNCAP Prostate | 337 / 14814 (2.3%) | 9416 / 148140 (6.4%) | −110.7 | −108.8 | 0.36 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 711 / 14814 (4.8%) | 14855 / 148140 (10.0%) | −110.6 | −108.8 | 0.48 |
Showing first 500 of 17376 rows.